Laura Tadvalkar, Managing Director, RA Capital Management
Laura Tadvalkar is a Managing Director on the Venture Team at RA Capital Management. Laura works on new company creation and early-stage investments, and serves as a Board Director for Hemab, Be Biopharma, Hyku Bioscience, and Typewriter Therapeutics. She was previously a Board Director at Mariana Oncology and Aliada Therapeutics. Prior to RA, Laura was a Principal at MP Healthcare Venture Management. Prior to MP, she was a Consultant at Clarion Healthcare. Laura holds a BS in Chemistry from Yale University and a PhD in Chemical Biology from Harvard University.
